1.
Breccia M, Cimino G, Diverio D, Gentilini F, Mandelli F, Lo Coco F. Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia. Haematologica [Internet]. 2007Sep.1 [cited 2026Nov.11];92(9):1273-4. Available from: https://haematologica.org/article/view/4576